Patents-Review.com
ClassID:

20974 ⎘

A61K38/2073 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interleukins [IL] IL-11

Recent Application in this class:
#1
20250387480
2025-12-25

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND AUTOIMMUNE CONDITIONS WITH ECM-AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS

 #2
20250339476
2025-11-06

ENGINEERED BACTERIAL THERAPEUTICS FOR THE TREATMENT OF GASTROINTESTINAL DISEASE

 #3
20250205308
2025-06-26

Supraparticles

 #4
20250092126
2025-03-20

TREATMENT AND PREVENTION OF ALCOHOLIC LIVER DISEASE

 #5
20240269175
2024-08-15

COMPOSITIONS AND METHODS OF CELLULAR IMMUNOTHERAPY

 #6
20240156913
2024-05-16

TREATMENT AND PREVENTION OF METABOLIC DISEASES

 #7
20230135903
2023-05-04

Improved Supraparticles

 #8
20220362337
2022-11-17

Method of treatment

 #9
20220331425
2022-10-20

TREATMENT OF CANCERS WITH GM-CSF ANTAGONISTS

 #10
20220249575
2022-08-11

FORMULATION AND TREATMENT FOR OPHTHALMIC DISORDERS

 #11
20220213184
2022-07-07

IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

 #12
20220213183
2022-07-07

IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

 #13
20220204606
2022-06-30

IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

 #14
20220202903
2022-06-30

Hematopoietic growth factor proteins and analogs thereof and angiotensin converting enzyme inhibitors for treatment of radiation exposure

 #15
20220118089
2022-04-21

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND AUTOIMMUNE CONDITIONS WITH ECM-AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS

 #16
20220040174
2022-02-10

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

 #17
20210401836
2021-12-30

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

 #18
20210268117
2021-09-02

Methods of preparing a pegylated human IL-11 composition

 #19
20210205414
2021-07-08

TREATMENTS FOR MIGRAINE AND RELATED DISORDERS

 #20
20210177940
2021-06-17

TREATMENT AND PREVENTION OF METABOLIC DISEASES

 #21
20210077591
2021-03-18

COMBINATION THERAPY FOR THE TREATMENT OF MIGRAINES

 #22
20200384083
2020-12-10

Treatment and prevention of metabolic diseases

 #23
20200377585
2020-12-03

IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

 #24
20200108156
2020-04-09

Enzyme-responsive peptide nanofiber compositions and uses thereof

 #25
20200038509
2020-02-06

RADIOFREQUENCY FIELD HYPERTHERMIA AND SOLID TUMOR IMMUNOMODULATION

 #26
20200000879
2020-01-02

Method of treatment

 #27
20190381042
2019-12-19

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

 #28
20190374612
2019-12-12

TREATMENTS FOR MIGRAINE AND RELATED DISORDERS

 #29
20190374541
2019-12-12

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

 #30
20190365909
2019-12-05

Methods of treatment using a branched amino terminal pegylated Il-11 composition

 #31
20190365908
2019-12-05

Interleukin-11 PEGylation reaction intermediate composition

 #32
20190255151
2019-08-22

Mesenchymal stem cells expressing anti-inflammatory cytokines and methods of use

 #33
20190151362
2019-05-23

Compositions and methods of cellular immunotherapy

 #34
20190016764
2019-01-17

Fusion polypeptide in which anti-inflammatory polypeptide and ferritin monomer fragment are bound and pharmaceutical composition for preventing and treating inflammatory diseases, containing same as active ingredient

 #35
20180339021
2018-11-29

Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure

 #36
20180296697
2018-10-18

Enzyme-responsive peptide nanofiber compositions and uses thereof

 #37
20180104243
2018-04-19

Tricyclic Amino Containing Compounds for Treatment or Prevention of Symptoms Associated with Endocrine Dysfunction

 #38
20180036418
2018-02-08

Increasing serum half-life of human IL-11 variants by N-terminal branched PEGylation

 #39
20180036380
2018-02-08

Treatments for migraine and related disorders

 #40
20170247690
2017-08-31

ONCOVIRAL TREATMENT WITH NUCLEASE AND CHEMOTHERAPEUTIC

 #41
20170080055
2017-03-23

Hematopoietic growth factor proteins and analogs thereof and angiotensin converting enzyme inhibitors for treatment of radiation exposure

 #42
20170035852
2017-02-09

Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure

 #43
20170000853
2017-01-05

WOUND HEALING COMPOSITION

 #44
20160324924
2016-11-10

COMPOSITIONS AND METHODS FOR TREATMENT OF EXERCISE-INDUCED PULMONARY HEMORRHAGE OR NASOPHARYNGEAL CICATRIX

 #45
20160263194
2016-09-15

Treatments for migraine and related disorders

 #46
20140294761
2014-10-02

Treatments for migraine and related disorders

 #47
20140248236
2014-09-04

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

 #48
20130302277
2013-11-14

METHOD OF TREATMENT

 #49
20130230485
2013-09-05

Methods for Treating Patients Undergoing Multi-Cycle Chemotherapy

 #50
20130202553
2013-08-08

Mobilization of hematopoietic stem cells

 #51
20130178425
2013-07-11

Methods and compositions for delivering interleukin-1 receptor antagonist

 #52
20130171097
2013-07-04

Method for the prophylactic or therapeutic treatment of glucocorticoid-induced osteoporosis

 #53
20130171096
2013-07-04

Immunobinders directed against sclerostin

 #54
20120288475
2012-11-15

Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure

 #55
20120258072
2012-10-11

Interleukin-11 Fusion Proteins

 #56
20120134958
2012-05-31

HYDROXYETHYL STARCH-CONTAINING POLYPEPTIDE COMPOSITIONS

 #57
20110318301
2011-12-29

IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

 #58
20110256126
2011-10-20

IL-17A/F Heterologous Polypeptides and Therapeutic Uses Thereof

 #59
20110236305
2011-09-29

METHODS FOR PROTECTING AND REGENERATING BONE MARROW USING CXCR3 AGONISTS AND ANTAGONISTS

 #60
20110229435
2011-09-22

Expression and purification of HIP/PAP and uses therefor

 #61
20110091415
2011-04-21

Hydroxyethyl Starch-Containing Polypeptide Compositions

 #62
20110020311
2011-01-27

Therapy of neurological inflammatory diseases with (5'-deoxy-5'-adenosyl) cobamamide, recombinant human growth hormone, interleukins IL-1, IL-6, IL-11, epidermal growth factor, and physiotherapy

 #63
20110020274
2011-01-27

Mobilization of hematopoietic stem cells

 #64
20100266591
2010-10-21

METHOD OF TREATING ERYTHROPOIETIN HYPORESPONSIVE ANEMIAS

 #65
20100183544
2010-07-22

Method of treatment of gastrointestinal-type cancer with antagonistic antibodies to IL-11R

 #66
20100172922
2010-07-08

Expression and purification of HIP/PAP and uses therefor

 #67
20100143973
2010-06-10

Interleukin-11 Fusion Proteins

 #68
20100129372
2010-05-27

INHIBITION OF PACAP SIGNALLING FOR THE PREVENTION AND TREATMENT OF THROMBOCYTOPENIA

 #69
20100119476
2010-05-13

SELECTION OF PEPTIDES SPECIFIC FOR HUMAN BLOOD OUTGROWTH ENDOTHELIAL CELLS

 #70
20100093976
2010-04-15

Use of interleukin-11 as therapeutic agent for heart disease

 #71
20100080756
2010-04-01

Methods for protecting and regenerating bone marrow using CXCR3 agonists and antagonists

 #72
20100062058
2010-03-11

Delayed Release Formulations for Oral Administration of a Polypeptide Therapeutic Agent and Methods of Using Same

 #73
20090191147
2009-07-30

Use of Interleukin-11 to Prevent Immune-Mediated Cytotoxicity

 #74
20090185996
2009-07-23

HYDROXYETHYL STARCH-CONTAINING POLYPEPTIDE COMPOSITIONS

 #75
20090004136
2009-01-01

Compounds to promote regeneration of bone marrow

 #76
20080292581
2008-11-27

Interleukin-11 Fusion Proteins

 #77
20080234234
2008-09-25

Compounds to promote regeneration of bone marrow

 #78
20080161540
2008-07-03

IL-17A/F heterologous polypeptides and therapeutic uses thereof

 #79
20080069796
2008-03-20

Low Dose Treatment with an Interleukin-11 Analog

 #80
20070160577
2007-07-12

Interleukin-11 compositions and methods of use

 #81
20070160576
2007-07-12

IL-17A/F heterologous polypeptides and therapeutic uses thereof

 #82
20060270003
2006-11-30

IL-17A/F heterologous polypeptides and therapeutic uses thereof

 #83
20060159656
2006-07-20

Formulations for IL-11

 #84
20060122106
2006-06-08

Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof

 #85
20060079450
2006-04-13

Hydroxyethyl starch-containing polypeptide compositions

 #86
20060062785
2006-03-23

Inhibition of PACAP signalling for the prevention and treatment of thrombocytopenia

 #87
20060062760
2006-03-23

Use of interleukin-11 to prevent immune-mediated cytotoxicity

 #88
20050129658
2005-06-16

Topical formulation for delivery of interleukin-11

 #89
20050042200
2005-02-24

Method and composition for inducing weight loss